Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

February 24, 2026

Study Completion Date

February 24, 2026

Conditions

Sickle Cell Disease

Interventions

BIOLOGICAL

Hematopoietic stem cell transplantation

Haploidentical stem cell transplantation with pre-transplant immunosuppressive therapy

Trial Locations (1)

City of Hope Medical Center, Duarte

All Listed Sponsors

lead

City of Hope Medical Center

OTHER